2023-08-09 12:05:45 ET
- Marinus Pharmaceuticals ( NASDAQ: MRNS ) is scheduled to announce Q2 earnings results on Thursday, August 10th, before market open.
- The consensus EPS Estimate is -$0.71 and the consensus Revenue Estimate is $5.74M (+218.9% Y/Y).
- Over the last 1 year, MRNS has beaten EPS estimates 25% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 1 downward. Revenue estimates have seen 1 upward revision and 8 downward.
For further details see:
Marinus Pharmaceuticals Q2 2023 Earnings Preview